Veradermics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -5,368 | |
Net Income | -21,847 | -5,660 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -23,633 | -3,632 |
Cash | 21,766 | 53,084 |
Basic Shares | 35,077 | 201,334 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -25,903 | -16,454 | |
Net Income | -69,995 | -26,488 | -16,489 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -71,626 | -23,688 | -13,510 |
Cash | 21,766 | 53,084 | 16,296 |
Basic Shares | 35,077 | 201,334 | 201,334 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.75 |
